• Dlin-MC3-DMA for Precision RNA LNP Workflows

  2026-09-22

  Dlin-MC3-DMA combines pH-responsive endosomal escape with a practical formulation workflow for siRNA and mRNA studies. This guide connects hepatic gene silencing benchmarks with machine-learning-assisted microglia assays, while providing executable preparation and troubleshooting parameters.

• Viral RIPK3 Degradation and Orthopoxvirus Inflammation

  2026-09-22

  Liu et al. identified a viral inducer of RIPK3 degradation, or vIRD, that links orthopoxvirus immune evasion to SCF-dependent ubiquitination and proteasomal turnover of the necroptosis adaptor RIPK3. Genetic and infection models showed that this pathway influences necroptosis, inflammation, viral replication, and disease severity, providing a framework for studying host–pathogen control of regulated cell death.

• PARP7, STAT1/2, and EAE: Mechanistic Insights

  2026-09-21

  Xu et al. show that PARP7 suppresses type I interferon signaling by ADP-ribosylating STAT1 and STAT2, promoting ubiquitination and p62-dependent autophagic degradation rather than simply blocking interferon production. In mice, PARP7 inhibition restored pathway activity and reduced experimental autoimmune encephalomyelitis, providing a mechanistic framework for autoimmune encephalomyelitis research while leaving translation to multiple sclerosis research open.

• EVMPs for Extrahepatic mRNA Delivery

  2026-09-21

  This ACS Nano study presents a bottom-up, self-assembling enveloped virus-mimicking particle that combines an engineered RNA-binding peptide with tunable phospholipid envelopes for organ-selective mRNA delivery. The optimized system produced substantial lung-cell transfection and enabled IL-12 mRNA-mediated tumor suppression, while its modular nonviral architecture addressed important limitations of conventional hepatic delivery platforms.

• Nirmatrelvir Workflows for SARS-CoV-2 3CL Protease

  2026-09-20

  Build reproducible SARS-CoV-2 3CL protease assays with Nirmatrelvir (PF-07321332), from solvent handling to orthogonal validation. This guide also shows how to use the compound as a mechanistic benchmark when translating docking predictions into antiviral therapeutics research.

• Protease Inhibitor Cocktail: EDTA-Free Workflow

  2026-09-19

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit broad proteolytic degradation during protein extraction and protease-sensitive downstream assays. It is suited to Western blotting, co-immunoprecipitation, pull-down, imaging, and kinase workflows, but it should not be treated as universal protection or as a substitute for assay-specific compatibility testing.

• Electrical Stimulation Boosts Nanoparticle Uptake

  2026-09-18

  The reference study demonstrates that alternating-current electrical stimulation increases magnetic nanoparticle endocytosis in cancer cells, primarily through macropinocytosis associated with altered F-actin and intracellular Ca2+ levels. The approach improves magnetic hyperthermia and MRI-related outcomes across multiple cell types and nanoparticle compositions without requiring extensive particle-surface functionalization.

• Multiomics of Crossbreeding and Sex in Xingguo Gray Goose

  2026-09-18

  This study integrates RNA sequencing and nontargeted metabolomics to examine how crossbreeding and sex shape growth, carcass traits, and meat quality in Xingguo gray geese. Its main contribution is a comparison-specific molecular framework linking altered gene expression and metabolites with muscle development and lipid metabolism, while also showing improved production traits in ternary hybrids.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-17

  Sulfo-NHS-LC-Biotin is a water-compatible reagent for stable covalent biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is appropriate for biotin-avidin detection and streptavidin capture workflows, but not for reversible labeling or intracellular labeling of intact cells.

• Brefeldin A Workflows for ER–Golgi Studies

  2026-09-17

  Brefeldin A provides an acute way to perturb ER–Golgi trafficking, ER stress, secretion, and cancer-cell phenotypes in a single experimental framework. This guide combines dose–time optimization, orthogonal readouts, and endothelial-barrier considerations to help distinguish trafficking effects from nonspecific cytotoxicity.

• Oligo (dT) 25 Beads: mRNA Isolation Guide

  2026-09-16

  Oligo (dT) 25 Beads provide a magnetic workflow for enriching polyadenylated eukaryotic mRNA from total RNA or eukaryotic cells and tissues. They are not a universal total-RNA purification reagent and should not be expected to efficiently capture non-polyadenylated transcripts or most prokaryotic mRNA.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-09-16

  A 2025 study links quercetin-mediated protection against cataract-related lens injury to suppression of Hippo pathway activity, improved redox balance, and preservation of lens epithelial-cell proliferation. Its combined network-pharmacology, animal, and cell-based design provides a useful framework for testing pathway-dependent protection while also highlighting the limits of translating oxidative-stress models into clinical cataract therapy.

• Oligo (dT) 25 Beads for mRNA Purification

  2026-09-15

  Oligo (dT) 25 Beads (SKU K1306) are intended for magnetic enrichment of polyadenylated eukaryotic mRNA from total RNA or suitable animal and plant samples. They should not be treated as a universal RNA purification reagent because non-polyadenylated transcripts, bacterial RNA, and poorly preserved samples may not be efficiently recovered.

• Cocaine, Astrocyte Ca2+ Signals, and Norepinephrine

  2026-09-15

  This study shows that cocaine produces synchronized, hyperactive Ca2+ fluctuations in prefrontal cortical astrocytes in awake mice through enhanced locus coeruleus norepinephrine transmission. By linking α1-adrenergic receptor activation to IP3R2-dependent store release and behavioral sensitization, the work establishes astrocytes as active participants in cocaine-related circuit adaptations.

• Phillygenin and Diabetic Nephropathy: Mechanistic Insights

  2026-09-14

  This study identifies phillygenin as a candidate intervention for diabetic nephropathy and links its protective effects to coordinated regulation of TLR4/MyD88/NF-κB inflammation and PI3K/AKT/GSK3β survival signaling. Using high-glucose podocytes, transcriptomics, molecular assays, and db/db mice, the work connects reduced cytokine production and apoptosis with improved renal injury markers.

8089 records 1/540 page Next 12345 下5页 Last page